Previous 10 | Next 10 |
home / stock / nvsef / nvsef news
Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analy...
Another week, another sector came under the scrutiny of the Chinese government, helping to divert market players from the internet stocks. There are silver linings from the Macau casino regulatory scrutiny that could benefit the Chinese internet sector. Baidu announced several pos...
A new report from UBS looks to dig into the most crowded trades in the market - the 10 stocks that are most overweight among global active investment funds, as well as the 10 most underweight. It's gone about that by forming an active trading portfolio aggregating positions across global acti...
Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting services for individuals, institutions, partnerships, pension and profit-sharing plans, charitable foundations, trusts, and offshore funds. Tweedy,...
Kahn Brothers’ 13F portfolio value increased from $646M to $698M this quarter. BP plc and Pfizer were increased, while decreasing Nam Tai Property and BlackBerry during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~...
Fisher’s 13F portfolio value increased from ~$142B to ~$159B in Q2 2021. The Vanguard Intermediate-Term Corporate Bond ETF stake was increased substantially this quarter. The top three positions are Apple, Microsoft, and Amazon. They add up to ~14% of the portfolio. F...
Novartis AG (NVS) Q2 2021 Earnings Conference Call July 21, 2021 8:00 a.m. ET Company Participants Samir Shah - Global Head of Investor Relations Vas Narasimhan - Chief Executive Officer Marie-France - President of Novartis Pharmaceuticals Susanne Schaffert - President of Novartis Oncology Ha...
The following slide deck was published by Novartis AG in conjunction with their 2021 Q2 earnings call. For further details see: Novartis AG 2021 Q2 - Results - Earnings Call Presentation
Insilico Medicine, a Hong Kong company devoted to using AI to speed up drug discovery and R&D, closed a $255 million Series C round led by Warburg Pincus. Jointech, a Hangzhou medical device company, has raised $62 million over the last 15 months to support its orthopedic surgery ...
The following slide deck was published by Novartis AG in conjunction with this event. For further details see: Novartis (NVS) Iptacopan (LNP023) Update - Slideshow
News, Short Squeeze, Breakout and More Instantly...
Novartis Ag Basel Akt Company Name:
NVSEF Stock Symbol:
OTCMKTS Market:
Novartis Ag Basel Akt Website:
FDA approval of the company’s second US Radioligand Therapy (RLT) manufacturing facility increases RLT production capacity to 250,000 doses in 2024 and beyond New 70,000-square foot RLT facility is the company’s largest and most advanced in the world to date and centrall...
APPLY-PNH extension data show that continuous Fabhalta ® (iptacopan) treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH) enabled sustained hemoglobin-level increases to near-normal (≥12 g/dL), blood transfusion avoidance, and improved patient-reported fatigu...
With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali ® (ribociclib) investigational treatment, the updated analysis shows sustained iDFS benefit and stability in secondary endpoints including overall survival (OS) 1,2 iDFS...